Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 1096980, 12 pages
https://doi.org/10.1155/2017/1096980
Research Article

Hepatoma-Derived Growth Factor Secreted from Mesenchymal Stem Cells Reduces Myocardial Ischemia-Reperfusion Injury

1Department of Cardiology, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Rd, Hangzhou 310009, China
2Cardiovascular Key Laboratory of Zhejiang Province, 88 Jiefang Rd, Hangzhou 310009, China

Correspondence should be addressed to Jian-An Wang; moc.oohay@gnaw_na_naij

Received 25 May 2017; Accepted 4 October 2017; Published 14 November 2017

Academic Editor: Yanfang Chen

Copyright © 2017 Yu Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., “Heart disease and stroke statistics—2012 update: a report from the American Heart Association,” Circulation, vol. 125, pp. e2–e220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Wu, J. L. Tan, Z. H. Wang et al., “ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca2+ overload and contractile dysfunction via the JAK2/STAT3 pathway,” Journal of Molecular and Cellular Cardiology, vol. 81, pp. 150–161, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Lopez-Bernardo, A. Anedda, P. Sanchez-Perez, B. Acosta-Iborra, and S. Cadenas, “4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes,” Free Radical Biology & Medicine, vol. 88, pp. 427–438, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. C. Awasthi, K. V. Ramana, P. Chaudhary, S. K. Srivastava, and S. Awasthi, “Regulatory roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated signaling and toxicity,” Free Radical Biology & Medicine, vol. 111, pp. 235–243, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Eaton, J. M. Li, D. J. Hearse, and M. J. Shattock, “Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart,” The American Journal of Physiology, vol. 276, pp. H935–H943, 1999. View at Google Scholar
  6. S. T. Ji, H. Kim, J. Yun, J. S. Chung, and S. M. Kwon, “Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration: from cell priming to tissue engineering,” Stem Cells International, vol. 2017, Article ID 3945403, 13 pages, 2017. View at Publisher · View at Google Scholar
  7. K. Tamama and D. J. Barbeau, “Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells,” Stem Cells International, vol. 2012, Article ID 428403, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Hu, P. Chen, Y. Wu et al., “MiR-211/STAT5A signaling modulates migration of mesenchymal stem cells to improve its therapeutic efficacy,” Stem Cells, vol. 34, pp. 1846–1858, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Hu, L. Zhang, J. Jin et al., “Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis,” Stem Cells, vol. 33, pp. 1850–1862, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Hu, Y. Xu, Z. Zhong et al., “A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization,” Circulation Research, vol. 118, pp. 970–983, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Chen, R. Wu, W. Zhu et al., “Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin,” PLoS One, vol. 9, article e103587, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Hu, R. Wu, Z. Jiang et al., “Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning,” Stem Cells, vol. 32, no. 10, pp. 2702–2713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Timmers, S. K. Lim, I. E. Hoefer et al., “Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction,” Stem Cell Research, vol. 6, pp. 206–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Timmers, S. K. Lim, F. Arslan et al., “Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium,” Stem Cell Research, vol. 1, pp. 129–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. P. Baines, J. Zhang, G.-W. Wang et al., “Mitochondrial PKCε and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection,” Circulation Research, vol. 90, pp. 390–397, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Li, J. Shen, X. Wu et al., “Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion,” Medical Oncology, vol. 30, p. 587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Kishima, K. Yoshida, H. Enomoto et al., “Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells,” Hepato-Gastroenterology, vol. 49, pp. 1639–1644, 2002. View at Google Scholar
  18. S. S. Hsu, C. H. Chen, G. S. Liu et al., “Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas,” Journal of Neuro-Oncology, vol. 107, pp. 101–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yu, H. Shen, H. Yu et al., “Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis,” Molecular BioSystems, vol. 7, pp. 1908–1916, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. R. Budas, E. N. Churchill, and D. Mochly-Rosen, “Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury,” Pharmacological Research, vol. 55, pp. 523–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Tong, W. Chen, C. Steenbergen, and E. Murphy, “Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C,” Circulation Research, vol. 87, pp. 309–315, 2000. View at Publisher · View at Google Scholar
  22. M. O. Gray, J. S. Karliner, and D. Mochly-Rosen, “A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death,” Journal of Biological Chemistry, vol. 272, pp. 30945–30951, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. G. S. Liu, M. V. Cohen, D. Mochly-Rosen, and J. M. Downey, “Protein kinase C- ξ is responsible for the protection of preconditioning in rabbit cardiomyocytes,” Journal of Molecular and Cellular Cardiology, vol. 31, pp. 1937–1948, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. G. R. Budas, E. N. Churchill, M.-H. Disatnik, L. Sun, and D. Mochly-Rosen, “Mitochondrial import of PKCε is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury,” Cardiovascular Research, vol. 88, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Seki, S. Sanada, A. Y. Kudinova et al., “Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling,” Circulation Heart Failure, vol. 2, pp. 684–691, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. S. Jiang, G. B. Wen, Z. H. Tang, W. Srisakuldee, R. R. Fandrich, and E. Kardami, “High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases,” Canadian Journal of Physiology and Pharmacology, vol. 87, pp. 798–804, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Chen, E. E. Tredget, W. PY, and Y. Wu, “Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing,” PLoS One, vol. 3, article e1886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Wang, H. Yang, Z. Tang, G. Long, and W. Huang, “Wound dressing model of human umbilical cord mesenchymal stem cells-alginates complex promotes skin wound healing by paracrine signaling,” Stem Cells International, vol. 2016, Article ID 3269267, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Abrial, C. C. Da Silva, B. Pillot et al., “Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 68, pp. 56–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. E. Murry, R. B. Jennings, and K. A. Reimer, “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, vol. 74, pp. 1124–1136, 1986. View at Publisher · View at Google Scholar
  31. M. Ogbi and J. A. Johnson, “Protein kinase Cε interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning,” The Biochemical Journal, vol. 393, pp. 191–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. P. Baines, C. X. Song, Y. T. Zheng et al., “Protein kinase Cε interacts with and inhibits the permeability transition pore in cardiac mitochondria,” Circulation Research, vol. 92, pp. 873–880, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. O. Gray, H. Z. Zhou, I. Schafhalter-Zoppoth, P. Zhu, D. Mochly-Rosen, and R. O. Messing, “Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase Cε,” The Journal of Biological Chemistry, vol. 279, pp. 3596–3604, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. T. Saurin, D. J. Pennington, N. J. Raat, D. S. Latchman, M. J. Owen, and M. S. Marber, “Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts,” Cardiovascular Research, vol. 55, pp. 672–680, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Ping, H. Takano, J. Zhang et al., “Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning,” Circulation Research, vol. 84, pp. 587–604, 1999. View at Publisher · View at Google Scholar
  36. A. D. Everett, “Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart,” Developmental Dynamics, vol. 222, pp. 450–458, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. A. D. Everett, D. R. Lobe, M. E. Matsumura, H. Nakamura, and C. A. McNamara, “Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development,” Journal of Clinical Investigation, vol. 105, pp. 567–575, 2000. View at Publisher · View at Google Scholar
  38. A. D. Everett, J. V. Narron, T. Stoops, H. Nakamura, and A. Tucker, “Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 286, pp. L1194–L1201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Y. Tsang, W. Y. Tang, W. P. Tsang, N. N. Co, S. K. Kong, and T. T. Kwok, “Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells,” Apoptosis, vol. 13, pp. 1135–1147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. H. Wang, F. Davamani, S. C. Sue et al., “Cell surface heparan sulfates mediate internalization of the PWWP/HATH domain of HDGF via macropinocytosis to fine-tune cell signalling processes involved in fibroblast cell migration,” Biochemical Journal, vol. 433, pp. 127–138, 2011. View at Publisher · View at Google Scholar · View at Scopus